Showing 9151-9160 of 18562 results for "".
- Impact of Lifestyle and Emotional Health on Skin Ulcers: Clinical Insights from Recent Researchhttps://reachmd.com/news/impact-of-lifestyle-and-emotional-health-on-skin-ulcers-clinical-insights-from-recent-research/2484233/A recent MDPI analysis links modifiable lifestyle and emotional factors to higher skin ulcer burden. The investigators performed a cross‑sectional analysis of a single‑center pathology registry
- Study IDs Additional Risk Allele in Allopurinol-Induced Cutaneous Reactions in US Patientshttps://reachmd.com/news/study-ids-additional-risk-allele-in-allopurinol-induced-cutaneous-reactions-in-us-patients/2484235/A recently published genetic association study has identified HLA-A34:02 as an independent allele significantly associated with severe cutaneous adverse reactions (SCARs) to allopurinol in a US-based cohort. Researchers from
- Evolving Cardiovascular Trends in England: Insights from EHR Datahttps://reachmd.com/news/evolving-cardiovascular-trends-in-england-insights-from-ehr-data/2484222/A landmark analysis of linked EHRs from 57 million people in England found that new cardiovascular diagnoses fell during the initial COVID-19 lockdown
- Breakthrough in Vision Restoration: BCI Retinal Implant Offers New Hope for AMD Patientshttps://reachmd.com/news/breakthrough-in-vision-restoration-bci-retinal-implant-offers-new-hope-for-amd-patients/2484218/A wireless BCI retinal implant restored form central vision in patients with geographic atrophy in a peer-reviewed New England Journal of Medicine trial
- Advancements in Image-Guided Bleomycin Electrosclerotherapy for Vascular Anomalieshttps://reachmd.com/news/advancements-in-image-guided-bleomycin-electrosclerotherapy-for-vascular-anomalies/2484107/Bleomycin electrosclerotherapy (BEST) is a validated, minimally invasive option for treatment‑resistant vascular anomalies, offering improved lesion reduction with an acceptable safety profile, according to a recent review in
- Emerging Sensor Technologies in Gastrointestinal Diagnostics: Spotlight on Ingestible Capsuleshttps://reachmd.com/news/emerging-sensor-technologies-in-gastrointestinal-diagnostics-spotlight-on-ingestible-capsules/2484114/The FireFLI capsule, a firefly-inspired ingestible biosensor, could enable earlier, noninvasive detection of intestinal inflammation and ischemia—potentially shifting time-to-diagnosis for conditions often recognized too late. According to
- Impact of 2025 CPR Guidelines on Emergency Care and Resuscitation Educationhttps://reachmd.com/news/impact-of-2025-cpr-guidelines-on-emergency-care-and-resuscitation-education/2484101/In a significant move toward improving outcomes for infants and children experiencing cardiac emergencies, the American Academy of Pediatrics (AAP) and the American Heart Association (AHA) have jointly released
- Recent Advances in Wireless Retinal Prostheses: Visual Outcomes and Safety Insightshttps://reachmd.com/news/recent-advances-in-wireless-retinal-prostheses-visual-outcomes-and-safety-insights/2484112/In a world-first, researchers have restored meaningful vision to patients with advanced macular degeneration using a wireless retinal implant and high-tech glasses — a breakthrough that could transform the treatment of irreversible blindness. The clinical trial, led by Stanford Medi
- Prenatal Air Pollution Exposure and Autism Risk: Clinical Insightshttps://reachmd.com/news/prenatal-air-pollution-exposure-and-autism-risk-clinical-insights/2484100/A sweeping new study of more than 2.1 million births in Ontario, Canada, has identified a significant association between prenatal exposure t
- FDA Expands Sotatercept Indication for PAH: A Closer Look at Clinical Impactshttps://reachmd.com/news/fda-expands-sotatercept-indication-for-pah-a-closer-look-at-clinical-impacts/2484099/The U.S. Food and Drug Administration (FDA) has approved an expanded indication for WINREVAIR™ (sotatercept-csrk), offering new hope for adults with pulmonary arterial hypertension (PAH, WHO Group 1) at high risk for clinical worsening.